The Latest Cardiac and Vascular News
Coverage policy improves access to artificial intelligence-enabled plaque analysis providing insights to help physicians guide treatment decisions for patients with coronary artery disease Coverage policy improves access to artificial intelligence-enabled plaque analysis providing insights to help physicians guide treatment decisions for patients with coronary artery disease
Enrollment completed ahead of schedule in the global IDE for Abbott’s Volt™ PFA System Global FOCALFLEX trial now underway for Abbott’s TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ Advisor™ HD Grid X Mapping Catheter, Sensor Enabled™, receives U.S. Food and Drug Administration…
OKLAHOMA CITY, Oct. 9, 2024 /PRNewswire/ — OU Health, the flagship academic health system of the University of Oklahoma, has performed its first pediatric heart transplant in decades at Oklahoma Children’s Hospital OU Health, marking a significant milestone in pediatric cardiac care for…
Shocking Increase in Heart Failure Prevalence, Mortality, and Impact on Younger Patients WASHINGTON, Sept. 24, 2024 /PRNewswire/ — The latest findings on heart failure (HF) published by Heart Failure Society of America (HFSA) reveal a concerning rise in the prevalence, mortality, and…
WALLINGFORD, Conn. and TAMPA, Fla., Sept. 11, 2024 /PRNewswire/ — InsiteOne, NewVue.AI, and RADPAIR are thrilled to announce a groundbreaking strategic contract with Aligned Radiology, a leading teleradiology provider. This collaboration combines advanced AI-driven workflow…
CHICAGO–(BUSINESS WIRE)–New international cardiology guidelines require the use of an ultrasound enhancing agent during stress echocardiograms to assess myocardial perfusion in patients with ischemia, as well as left ventricular heart function, according to a British cardiologist who is a co-author […]
V-Wave’s Novel and Minimally Invasive Interatrial Shunt is Designed to Treat Heart Failure and Addresses Significant Treatment Gap Device Further Strengthens Johnson & Johnson MedTech’s Position in Cardiovascular August 20, 2024 07:30 AM Eastern Daylight Time NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson […]
BURLINGTON, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) — LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2024 results, announced a $0.16/share quarterly dividend and provided guidance.
– ATEV demonstrated superiority at six and 12 months (co-primary endpoints) compared to autogenous fistula, the current standard of care for hemodialysis –
CLEVELAND – A novel study co-authored by a heart failure cardiologist at University Hospitals Harrington Heart & Vascular Institute, demonstrates the effectiveness of a newly developed scoring system in identifying patients with Heart Failure with Preserved Ejection Fraction (HFpEF). The […]
